Immunotherapy Against Invasive Fungal Diseases in Stem Cell Transplant Recipients

Despite the availability of new antifungal compounds, morbidity and mortality of invasive fungal disease in allogeneic hematopoietic stem cell recipients are still unacceptably high.

http://www.citeulike.org/user/Zephyrus/article/12542596